Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research

Study Overview
=================
Brief Summary
-----------------
Neuropsychiatric symptoms form part of the clinical picture of Alzheimer's disease (AD) and other dementias. Irrespective of the severity of the disease, the most frequently encountered symptom is apathy. Apathy is increasingly diagnosed in patients with neurological and psychiatric conditions. Apathy is a disorder of motivation, defined as the direction, intensity and persistence of goal-directed behaviour. Most of the current descriptions acknowledge this point and consider apathy in terms of a lack of goal-directed behaviour, cognition or emotion. The classical neuropsychiatric symptom assessments are subjective structured interview-based, using input from the caregiver and/or the patient. New technologies are likely to provide us with a more objective measure. An example is ambulatory actigraphy, consisting of a piezoelectric accelerometer designed to record arm movement in three dimensions. The aim of the present study is to assess using actigraphy and video recording signal, AD patients with (n = 15) and without (n = 15) apathy and control subjects (n = 5) during an activity of daily living scenario .

Official Title
-----------------
Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research

Conditions
-----------------
Alzheimer's Disease

Intervention / Treatment
-----------------
* Other: Actigraphy and video recording signal


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: male or female, > 65 years ; Alzheimer's disease according to the NINCDS-ADRDA criteria (McKhann,Drachman et al. 1984) ; Mini Mental Test Examination (MMSE) > 20 ; no motor anomaly according to UPDRS III (tremblements, rigidité musculaire) ; no depression criteria according to DSM IV-R criteria ; patient with a cholinergic treatment at dose stable since 3 months ; patient with social insurance ; signature of informed consent. Exclusion Criteria: neuropsychologics assessment impossible due to sensorial and disrupt ; prescription of psychotrop treatment (hypnotic, anxiolytic, antidepressant, antipsychotic) in the week previous actigraphy recording.

Ages Eligible for Study
-----------------
Minimum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Basic Science
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Other: Alzheimer and apathy<br>Alzheimer's disease patients with apathy | Other: Actigraphy and video recording signal<br>* Actigraphy and video recording signal during 1 hour<br>|
| Other: alzheimer without disease<br>Alzheimer's disease patients without apathy | Other: Actigraphy and video recording signal<br>* Actigraphy and video recording signal during 1 hour<br>|
| Other: Case control<br>subject without apathy neither Alzheimer's disease | Other: Actigraphy and video recording signal<br>* Actigraphy and video recording signal during 1 hour<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| assessment of motricity |  | one time point - at the only visit of protocol | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| video recording |  | one time point - at the only visit of the protocol | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
alzheimer, apathy, actigraphy